TotalMarketCap

Pyxis Oncology

PYXSNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$193.128 M

$1.62 -2.71%

Close of 6 Nov 2026

As of 6 Nov 2026, Pyxis Oncology (PYXS) has a market capitalization of $193.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$13.9M

#3064 by revenue

Earnings

-$79.6M

Loss-making

Shares outstanding

119,607,855

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #248Eledon PharmaceuticalsELDN$199.9M
  2. #249InflaRxIFRX$198.9M
  3. #250Pyxis OncologyPYXS$193.1M
  4. #251ProQR TherapeuticsPRQR$188.4M
  5. #252Keros TherapeuticsKROS$187.6M

What if Pyxis Oncology were worth as much as…

Open the what-if tool →

Gold $28.2T

$236,126.57

Per share 146,208× higher

Bitcoin $1.53T

$12,776.40

Per share 7,911× higher

Apple $5.02T

$41,943.72

Per share 25,971× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Pyxis Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.